Corium International Inc.   Report issue

For profit Phase 1 Phase 4
Founded: Menlo Park CA United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2016
NCT02968719
First Marketed Drug
2022
donepezil (aricept)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

CORIUM | Corium, Inc. | Corium International | Corium International Inc.